HealthQuill US
Pfizer Inc. has signed a licensing deal worth about $6 billion with China’s 3SBio to develop, manufacture and commercialise an experimental cancer drug.
Drugs Health Pharma

Pfizer signs $6 billion licensing deal with China’s 3SBio for cancer drug

HQ Team May 20, 2025: Pfizer Inc. has signed a licensing deal worth about $6 billion with China’s 3SBio to develop, manufacture and.

Read More
More than one in four cars sold worldwide is set to be electric this year, as the growth of electric vehicles is on course to exceed 40% in another five years, according to an International Energy Agency report.
Climate Health Research

Adaption of electric vehicles surges globally: One in four cars sold is an EV

HQ Team May 19, 2025: More than one in four cars sold worldwide is set to be electric this year, as the growth.

Read More
US President Donald Trump’s plan to raise taxes on private philanthropic foundations will harm charities' efforts to provide education, shelter, and food to the country's poor, experts said.
Drugs Health Pharma

US plan to raise taxes on charities a ‘disastrous’ move: Experts say

HQ Team May 19, 2025: US President Donald Trump’s plan to raise taxes on private philanthropic foundations will harm charities’ efforts to provide.

Read More
The Food and Drug Administration has cleared the first at-home cervical cancer screening test in the US, according to a statement from Teal Health, its maker.
Health Medical Pharma

US approves first at-home cervical cancer screening from Teal Health

HQ Team May 12, 2025: The Food and Drug Administration has cleared the first at-home cervical cancer screening test in the US, according.

Read More
Merck Animal Health will invest $895 million in its US facility to develop novel parasiticides and therapeutics, and expand, filling and freeze dryer capacity, according to a company statement.
Drugs Health Pharma

Merck Animal Health to invest $895 million to expand facility in US

HQ Team May 8, 2025: Merck Animal Health will invest $895 million in its US facility to develop novel parasiticides and therapeutics, and.

Read More
The Global Virus Network warned of an avian influenza currently circulating in the US, spreading to humans and urged enhanced surveillance, biosecurity measures and preparations for a potential human-to-human transmission.
Drugs Health Pharma

Global virologists see potential for an H5N1 pandemic, urge rapid steps

HQ Team May 5, 2025: The Global Virus Network warned of an avian influenza currently circulating in the US, spreading to humans and.

Read More
A ten-fold increase in measles cases was reported from Europe last year, while the numbers shot up 11-fold this year until April 18, in the American region, according to two global health agencies.
Drugs Health Medical

In Europe measles up 10-fold last year, Americas region up by 11-fold in 2025

HQ Team April 29, 2025: A ten-fold increase in measles cases was reported from Europe last year, while the numbers shot up 11-fold.

Read More
Swiss healthcare multinational F. Hoffmann-La Roche AG will invest $50 billion in the US over the next five years to expand its research and manufacturing facilities.
Drugs Medical Pharma

Roche to invest $50 billion in US over next five years to expand capacity

HQ Team April 22, 2025: Swiss healthcare multinational F. Hoffmann-La Roche AG will invest $50 billion in the US over the next five.

Read More
Generic drugs made in India, which account for 93% of such medicines made from emerging countries, are linked to hospitalisation, disability and in a few cases death, compared to the US, according to a study by the Ohio State University.
Drugs Health Research

Generic Indian drugs have a 54% higher risk compared to US

HQ Team April 18, 2025: Generic drugs made in India, which account for 93% of such medicines made from emerging countries, are linked.

Read More
Pfizer Inc. stopped its trial of danuglipron for treating chronic weight management after an asymptomatic patient developed a drug-induced liver injury that was resolved after discontinuation of the oral drug.
Uncategorized

Pfizer stops development of an investigational drug to treat obesity

HQ Team April 15, 2025: Pfizer Inc. stopped its trial of danuglipron for treating chronic weight management after an asymptomatic patient developed a.

Read More